Washington restates a long-running claim: more than 120 US-funded biolaboratories in over 30 countries

On 12 June 2026, the Office of the Director of National Intelligence released a statement from Tulsi Gabbard asserting that the United States government has funded "more than 120 biolaboratories in over 30 countries worldwide." The press release, circulated on 12 June 2026 at 18:37 UTC via the Telegram channel @intelslava, restates a claim that has circulated in Russian and Chinese state media for at least a decade and that Western fact-checkers and US defence agencies have repeatedly disputed or reframed. The reappearance of the figure, in an official US intelligence-release format rather than in a foreign-ministry briefing, is what makes the document news.

Gabbard's statement is unusual for two reasons. It puts a number — "more than 120" laboratories across "over 30 countries" — into a US-government format that, until now, has usually answered that question in the negative. And it arrives in a news cycle already saturated with allegations about the Wuhan Institute of Virology, the EcoHealth Alliance grant portfolio, and the 2024 reauthorization debate over the Foreign Assistance Act's biological-threat-reduction authorities. The question is no longer whether the United States runs an overseas biological-research footprint; it is how that footprint is described, who is allowed to describe it, and which descriptions count as evidence.

The press release and what it actually says

The DNI's statement does not, on the face of the Telegram excerpt, allege that any of the named facilities are engaged in offensive weapons work. It frames the funded laboratories as part of a defensive biodefence and disease-surveillance network — a description broadly consistent with the public posture of the Defense Threat Reduction Agency (DTRA), the US Army's overseas biological engagement programme, and the cooperative-threat-reduction agreements signed with partners from Ukraine to the Philippines since the 1990s. The novelty is the public, unhedged use of the word "biolaboratory" by a sitting Director of National Intelligence. That word has been the central linguistic battleground of the file for the better part of a decade: Russian and Chinese diplomats use it as a synonym for "clandestine weapons site," Western fact-checkers and scientists use it to mean "BSL-2 or BSL-3 research facility receiving US grant funding," and most ordinary readers land somewhere in between.

The press release therefore leaves the meaning of the number deliberately open. "More than 120" is consistent with the scale of DTRA's Biological Threat Reduction Program (BTRP), which has funded or renovated dozens of facilities across the former Soviet Union, the Middle East, Africa and South-East Asia. It is also consistent with the State Department's network of Biosafety Engagement Program labs, and with the Defence Threat Reduction Agency's bilateral portfolios in countries including Ukraine, Georgia, Kazakhstan, the Philippines, Vietnam, Cameroon, Sierra Leone, and the Democratic Republic of the Congo. The figure, on its own, tells the reader little about purpose, oversight, or weapons-relevance.

The counter-narrative, and the seam it lives in

For most of the past decade, the dominant Western wire framing has been that the "US biolabs" story is a Russian disinformation construct — an inverted mirror of the biological-weapons allegations Moscow has levelled at Washington since at least 2018. That framing has been carried by Reuters, the BBC, the Associated Press, Bellingcat, the EU East StratCom Task Force, and a series of State Department fact-sheets. The Ukrainian Security Service (SBU) has, in turn, used the existence of the laboratory network as evidence in domestic prosecutions of pro-Russian figures. The Chinese Ministry of Foreign Affairs has, since 2022, folded the same claims into its own critique of US biosecurity policy, particularly around the Wuhan Institute of Virology. The Global South press — from South Africa to the Philippines — has covered the story unevenly, with some outlets repeating Russian-language wire copy and others treating the network as a routine aid-and-surveillance programme.

The 2026 DNI statement is interesting precisely because it cuts across that seam. It is not a denial; it is a partial confirmation. By using the figure 120 and the word "biolaboratories" on the record, the Office of the Director of National Intelligence has conceded the scale of the footprint while declining to confirm the purpose that Russian and Chinese sources ascribe to it. The structural implication is awkward for both sides of the old argument. The Russian Foreign Ministry's talking-points — that the United States is running a covert network of weapons-capable facilities — do not become true because Washington admits to 120 sites. But the State Department's older position — that the claim is fundamentally fabricated — becomes harder to sustain when a sitting DNI repeats the underlying figure in an official release.

What the available sourcing does and does not establish

The sources available to this publication do not specify which countries host the 120 facilities, which agencies fund them, what the breakdown is between BSL-2 and BSL-3 capability, or whether any of the sites are subject to US-government inspection regimes. They also do not specify whether the figure includes non-laboratory investments — biosurveillance programmes, equipment grants, training pipelines, or contractor-run mobile units — that may or may not count as a "biolaboratory" in the conventional sense. The press release circulated by @intelslava is presented without a direct link to the ODNI website in the material reviewed, and the language is truncated at the end of the Telegram excerpt, leaving the full release unverified beyond its existence.

What can be said with more confidence is that the public footprint is large. The BTRP portfolio alone, as documented in successive Defense Department budget submissions, has run through at least 30 partner countries since 1998. The USAID PREDICT and Emerging Pandemic Threats programmes, which the Agency for International Development wound down in 2020 and partially relaunched in subsequent years, operated in roughly the same number of jurisdictions. The Centers for Disease Control and Prevention's Global Health Security Agenda work, the NIH Fogarty International Center, and the National Institute of Allergy and Infectious Diseases' overseas funding pipelines each add a layer. Adding those layers together produces a number plausibly in the 100-to-150 range — but each layer has a different legal authority, a different congressional overseer, and a different inspection regime, and most of them have, at one point or another, been the subject of partial funding restrictions from Congress.

Stakes and what to watch

The political stakes are not principally scientific. They are about who gets to define the vocabulary of biological security in a moment when the WHO Pandemic Agreement is being ratified, when the Biological Weapons Convention's verification protocol remains in stalemate, and when the United States is the world's largest funder of overseas health-security capacity. If a US intelligence officer can say "biolaboratory" in an official release without either confirming weapons-work or denying it, the term effectively becomes a placeholder for whatever each audience wants it to mean. That is precisely the position that Russian and Chinese diplomats have been trying to push the global conversation toward for years.

The trajectory to watch over the next 90 days is whether the DNI press release is followed by a White House or State Department fact-sheet that re-defines the 120 facilities in defensive-surveillance language, or whether the intelligence-community framing — and the word "biolaboratory" — survives into formal policy documents. The former would re-establish the older Western wire line and treat the Gabbard statement as an aberration. The latter would mark a quiet shift in the United States' own public posture, and would hand Moscow and Beijing a rhetorical victory they have not yet earned on the merits. Either way, the file is no longer one that can be closed by fact-check alone.

Desk note: Monexus treated the Gabbard statement as a primary release and the Russian-language Telegram circulation as a distribution channel rather than an editorial source. The article does not assert that any of the 120 facilities are engaged in offensive work — that claim is not supported by the materials reviewed.

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

• https://t.me/intelslava
• https://en.wikipedia.org/wiki/Biological_Threat_Reduction_Program
• https://en.wikipedia.org/wiki/Tulsi_Gabbard
• https://en.wikipedia.org/wiki/Office_of_the_Director_of_National_Intelligence